$BTHE Boston Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Boston Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Boston Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Boston Therapeutics, Inc. for free.
IRS Number: 270801073
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: BTHE
Company Address: 354 MERRIMACK STREET #4 LAWRENCE 01843
Phone number: 603-935-9799
Former name: AVANYX Therapeutics, Inc., date of change: 2009-10-01
Boston Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2015 | NO SYMBOL | Boston Therapeutic ... | CONAWAY DALE H | Director | Buy | P | 0.12 | 5,000 | 600 | 7,100 | 2.1 K to 7.1 K (+238.10 %) |
| May 18 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.15 | 1,000 | 148 | 7,561,985 | 7.6 M to 7.6 M (+0.01 %) |
| May 18 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.12 | 5,000 | 600 | 7,560,985 | 7.6 M to 7.6 M (+0.07 %) |
| Mar 20 2015 | NO SYMBOL | Boston Therapeutic ... | ESBER HENRY JEMIL | Director | Option Exercise | A | 0.37 | 6,000 | 2,220 | 228,000 | |
| Mar 20 2015 | NO SYMBOL | Boston Therapeutic ... | ESBER HENRY JEMIL | Director | Buy | P | 0.20 | 9,000 | 1,800 | 13,000 | 4 K to 13 K (+225.00 %) |
| Mar 16 2015 | NO SYMBOL | Boston Therapeutic ... | Hoberman Alan M | Director | Buy | P | 0.22 | 5,000 | 1,100 | 5,000 | 0 to 5 K |
| Mar 11 2015 | NO SYMBOL | Boston Therapeutic ... | SQUEGLIA ANTHONY DON | Chief Financial Off ... | Buy | P | 0.22 | 10,000 | 2,200 | 128,350 | 118.4 K to 128.4 K (+8.45 %) |
| Mar 10 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.25 | 1,250 | 306 | 7,555,985 | 7.6 M to 7.6 M (+0.02 %) |
| Mar 10 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.24 | 465 | 112 | 7,554,735 | 7.6 M to 7.6 M (+0.01 %) |
| Mar 10 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.23 | 2,285 | 526 | 7,554,270 | 7.6 M to 7.6 M (+0.03 %) |
| Mar 10 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.21 | 3,000 | 630 | 7,551,985 | 7.5 M to 7.6 M (+0.04 %) |
| Mar 10 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.21 | 3,000 | 615 | 7,548,985 | 7.5 M to 7.5 M (+0.04 %) |
| Feb 19 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.58 | 250 | 145 | 7,545,985 | 7.5 M to 7.5 M (0.00 %) |
| Feb 13 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.51 | 250 | 128 | 7,545,735 | 7.5 M to 7.5 M (0.00 %) |
| Feb 04 2015 | NO SYMBOL | Boston Therapeutic ... | PLATT DAVID | CEO and Chairman | Buy | P | 0.41 | 200 | 82 | 7,545,485 | 7.5 M to 7.5 M (0.00 %) |